Hager Investment Management Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Sell
450
-390
-46% -$10.2K 0.01% 247
2026
Q1
$23.6K Hold
840
0.01% 184
2025
Q4
$20.9K Sell
840
-341
-29% -$8.6K 0.01% 177
2025
Q3
$30.1K Sell
1,181
-304
-20% -$7.5K 0.02% 167
2025
Q2
$36K Hold
1,485
0.02% 155
2025
Q1
$37.6K Sell
1,485
-135
-8% -$3.53K 0.03% 145
2024
Q4
$43K Buy
+1,620
New +$43.9K 0.03% 141

Other funds holding PFE

Hager Investment Management Services's PFE Position: Q2 2026 in Review

Hager Investment Management Services reduced its Pfizer (PFE) stake by 46% in Q2 2026, selling an estimated $10.2K and leaving 450 shares worth $10.8K. The position accounts for 0.01% of the portfolio, ranked #247.

Hager Investment Management Services first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $43K in Q4 2024. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hager Investment Management Services held 450 shares of Pfizer worth $10.8K as of Q2 2026.
  • Hager Investment Management Services sold 390 Pfizer shares in Q2 2026, an estimated $10.2K.
  • Pfizer made up 0.01% of Hager Investment Management Services's portfolio in Q2 2026, its #247 holding.
  • Hager Investment Management Services first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Hager Investment Management Services's Pfizer position peaked at $43K in Q4 2024.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.